ES2154604A1 - Medicacion de uso topico aplicable para el tratamiento de enfermedades producidas por virus, especialmente el herpes simplex de los tipos h sv1 y hsv2 - Google Patents

Medicacion de uso topico aplicable para el tratamiento de enfermedades producidas por virus, especialmente el herpes simplex de los tipos h sv1 y hsv2

Info

Publication number
ES2154604A1
ES2154604A1 ES009901992A ES9901992A ES2154604A1 ES 2154604 A1 ES2154604 A1 ES 2154604A1 ES 009901992 A ES009901992 A ES 009901992A ES 9901992 A ES9901992 A ES 9901992A ES 2154604 A1 ES2154604 A1 ES 2154604A1
Authority
ES
Spain
Prior art keywords
anilines
colors
medication
water soluble
hsv2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009901992A
Other languages
English (en)
Other versions
ES2154604B1 (es
Inventor
Valdes Jose Gonzalez-Regueral
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES9901992A priority Critical patent/ES2154604B1/es
Publication of ES2154604A1 publication Critical patent/ES2154604A1/es
Application granted granted Critical
Publication of ES2154604B1 publication Critical patent/ES2154604B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Medicación de uso tópico aplicable para el tratamiento de enfermedades producidas por virus, especialmente el Herpes Simplex de los tipos HSV1 y HSV2, que consiste en una solución de rojo neutro y/o anilina azul hidrosoluble y/o anilinas de otros colores, en diversos excipientes aprobados para su uso tópico cutáneo, en la terapéutica de las infecciones del Herpes Simplex HSV1 o HSV2, o de otras infecciones víricas.
ES9901992A 1999-09-06 1999-09-06 Medicacion de uso topico aplicable para el tratamiento de enfermedades producidas por virus, especialmente el herpes simplex de los tipos h sv1 y hsv2 Expired - Fee Related ES2154604B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9901992A ES2154604B1 (es) 1999-09-06 1999-09-06 Medicacion de uso topico aplicable para el tratamiento de enfermedades producidas por virus, especialmente el herpes simplex de los tipos h sv1 y hsv2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9901992A ES2154604B1 (es) 1999-09-06 1999-09-06 Medicacion de uso topico aplicable para el tratamiento de enfermedades producidas por virus, especialmente el herpes simplex de los tipos h sv1 y hsv2

Publications (2)

Publication Number Publication Date
ES2154604A1 true ES2154604A1 (es) 2001-04-01
ES2154604B1 ES2154604B1 (es) 2001-11-16

Family

ID=8309853

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9901992A Expired - Fee Related ES2154604B1 (es) 1999-09-06 1999-09-06 Medicacion de uso topico aplicable para el tratamiento de enfermedades producidas por virus, especialmente el herpes simplex de los tipos h sv1 y hsv2

Country Status (1)

Country Link
ES (1) ES2154604B1 (es)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996020932A1 (en) * 1995-01-06 1996-07-11 The Picower Institute For Medical Research Compounds and methods of use to treat infectious diseases

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996020932A1 (en) * 1995-01-06 1996-07-11 The Picower Institute For Medical Research Compounds and methods of use to treat infectious diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LAHAV, M. et al. "Photodynamic Inactivation in experimental herpetic keratitis". Archives of Ophtalmology (1975 Mar) 93 (3) 207-14. ISSN: 0003-9950 *
MYERS, M.G. et al. "Failure of neutral red photodynamic inactivation in recurrent herpes simplex virus infections". New England Journal of Medicine (1975 Nov 6) 293 (19) 945-9. ISSN 0028-4793 *

Also Published As

Publication number Publication date
ES2154604B1 (es) 2001-11-16

Similar Documents

Publication Publication Date Title
IL126924A0 (en) Antimicrobial treatment for herpes simplex virus and other infectious diseases
FR2712603B1 (fr) Virus recombinants, préparation et utilisation en thérapie génique.
NZ513450A (en) Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R,cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene- 1-methanol useful as antiviral agents
EP0759301A3 (en) Prevention and treatment of topical viral infections with perfluoropolyethers or their compositions
AU2006399A (en) Spectral optimization and joint signaling techniques for communication in the presence of cross talk
CA2130360A1 (en) Sulfonic Acid Derivatives in the Treatment of Viral Diseases
CA2311922A1 (en) Thienopyrimidines
FR2718150B1 (fr) Virus recombinants, préparation et utilisation en thérapie génique.
AU6886996A (en) Building plaything primarily for creating rolling tracks
AU3568600A (en) Antiviral composition
CA2158609A1 (en) 5 .alpha.-reductase inhibitors
ES2154604A1 (es) Medicacion de uso topico aplicable para el tratamiento de enfermedades producidas por virus, especialmente el herpes simplex de los tipos h sv1 y hsv2
DK0704501T3 (da) Højtransparente, røde jernoxidpigmenter, fremgangsmåde til deres fremstilling og anvendelse
EP0643074A3 (en) Inhibitors of viral infection and proliferation.
CA2255681A1 (en) Composition and method for treating herpes simplex
WO1994027584A3 (en) Arylating medicaments
AU7806187A (en) Sulphonamide derivatives for the treatment and prevention of viral diseases
AU2464000A (en) Male genitals protecting underpants
AU5505699A (en) Pharmaceutical preparations for the topical treatment of mucocutaneous herpes infections and herpetic keratitis of the eye
AU1873101A (en) Synergistic treatment of dna viral infections
WO2001066100A3 (en) Pharmaceutical composition
ZA955865B (en) The use of (s)-adenosyl-l-methionine (same) and its physiologically tolerated salts for treating reperfusion damage caused by temporary focal ischemia
MXPA02000485A (es) 2-amino-benzoxazinonas para el tratamiento del virus de herpes simple.
IL112992A0 (en) Recombinant viruses, their preparation and their use in gene therapy
UA23352A (uk) beta- D- ГЛЮКОЗАМОHІЙHА СІЛЬ alРha-БРОМІЗОВАЛЕРІАHОВОЇ КИСЛОТИ, ЯКА МАЄ ПРОТИВІРУСHУ АКТИВHІСТЬ ВІДHОСHО ВІРУСУ ВЕЗИКУЛЯРHОГО СТОМАТИТУ, ВІРУСУ ПРОСТОГО ГЕРПЕСУ ТА КОРОHАВІРУСУ

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010401

Kind code of ref document: A1

Effective date: 20010401

FD1A Patent lapsed

Effective date: 20100312